EUVIMEDEUVIMED entdecken
Open Access

Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR/Cas3

Jinze Li iD, Ding Zhao iD, Tao Zhang iD, Haoyang Xiong iD, Mingyang Hu iD, Hongmei Liu iD, Feiyu Zhao iD, Xiaodi Sun iD, Peng Fan iD, Yuqiang Qian iD, Di Wang iD, Liangxue Lai iD und 2 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.adk8052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Jinze Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Provincial Key Laboratory of Animal Embryo Engineering, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, the Cas9 and Cas12a systems are widely used for genome editing, but their ability to precisely generate large chromosome fragment deletions is limited. Type I-E CRISPR mediates broad and unidirectional DNA degradation, but controlling the size of Cas3-mediated DNA deletions has proven elusive thus far. Here, we demonstrate that the endonuclease deactivation of Cas9 (dCas9) can precisely control Cas3-mediated large-fragment deletions in mammalian cells. In addition, we report the elimination of the Y chromosome and precise retention of the Sry gene in mice using CRISPR/Cas3 and dCas9-controlled CRISPR/Cas3, respectively. In conclusion, dCas9-controlled CRISPR/Cas3-mediated precise large-fragment deletion provides an approach for establishing animal models by chromosome elimination. This method also holds promise as a potential therapeutic strategy for treating fragment mutations or human aneuploidy diseases that involve additional chromosomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsCRISPR-Associated ProteinsMiceHumansAnimalsGene EditingY ChromosomeDNAMammals

Substanzen

CRISPR-Associated ProteinsDNA

Autor:innen und Institutionen

  • Jilin Provincial Key Laboratory of Animal Embryo Engineering, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, J…
  • Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, Guangdong 510530, China.

ORCID-Profile: Jinze Li, Ding Zhao, Tao Zhang, Haoyang Xiong, Mingyang Hu, Hongmei Liu, Feiyu Zhao, Xiaodi Sun, Peng Fan, Yuqiang Qian, Di Wang, Liangxue Lai, Tingting Sui, Zhanjun Li

Zitieren

APA

Li, J., Zhao, D., Zhang, T., Xiong, H., Hu, M., Liu, H., Zhao, F., Sun, X., Fan, P., Qian, Y., Wang, D., Lai, L., Sui, T., & Li, Z. (2024). Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR/Cas3. Science Advances. https://doi.org/10.1126/sciadv.adk8052

Vancouver

Li J, Zhao D, Zhang T, Xiong H, Hu M, Liu H, et al. Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR/Cas3. Science Advances. 2024. doi:10.1126/sciadv.adk8052

BibTeX
@article{Li2024,
  author = {Li, Jinze and Zhao, Ding and Zhang, Tao and Xiong, Haoyang and Hu, Mingyang and Liu, Hongmei and Zhao, Feiyu and Sun, Xiaodi and Fan, Peng and Qian, Yuqiang and Wang, Di and Lai, Liangxue and Sui, Tingting and Li, Zhanjun},
  title = {Precise large-fragment deletions in mammalian cells and mice generated by dCas9-controlled CRISPR/Cas3},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adk8052}
}
Kostenlos starten →